The p110α isoform of phosphatidylinositol 3-kinase is essential for polyomavirus middle T antigen-mediated transformation

被引:25
|
作者
Utermark, Tamara
Schaffhausen, Brian S.
Roberts, Thomas M.
Zhao, Jean J.
机构
[1] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA
[4] Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA
关键词
D O I
10.1128/JVI.00115-07
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Middle T antigen (MT) of polyomavirus is known to play an important role in virus-mediated cellular transformation. While MT has been extensively examined in spontaneously immortalized rodent fibroblasts, its interactions with cells of other types and species are less well understood. We have undertaken a cross-species and cross-cell-type comparison of MT-induced transformation in cells with genetically defined backgrounds. We tested the transforming abilities of a panel of MT mutants, Y250F, Y315F, and Y322F, that are selectively mutated in the binding sites for the principal effectors of MT-Src homology 2 domain-containing transforming protein, phosphatidylinositol 3-kinase (PI3K), and phospholipase C-gamma, respectively-in fibroblasts and epithelial cells of murine or human origin. We found that the Y315F mutation disabled the ability of MT to induce transformation in all cell types and species tested. While Y315F also failed to activate the PI3K pathway in these cells, genetic evidence has indicated Y315 may make other contributions to transformation. To confirm the role of PI3K, the PIK3CA gene, encoding p110 alpha, the prime effector of PI3K signaling downstream from activated growth factor receptors, was genetically ablated. This abolished the transforming activity of MT, demonstrating the essential role for this PI3K isoform in MT-mediated transformation. The Y250F mutant was able to transform the human, but not the murine, cells that were examined. Interestingly, this mutant fully activates the PI3K pathway in human cells but activated PI3K signaling poorly in the murine cells used in the study. This again points to the importance of PI3K activation for transformation and suggests that the mechanism by which MT activates the PI3K pathway differs in different species.
引用
收藏
页码:7069 / 7076
页数:8
相关论文
共 50 条
  • [31] A crucial role for the p110δ subunit of phosphatidylinositol 3-kinase in B cell development and activation
    Clayton, E
    Bardi, G
    Bell, SE
    Chantry, D
    Downes, CP
    Gray, A
    Humphries, LA
    Rawlings, D
    Reynolds, H
    Vigorito, E
    Turner, M
    JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (06): : 753 - 763
  • [32] Monocyte p110α phosphatidylinositol 3-kinase regulates phagocytosis, the phagocyte oxidase, and cytokine production
    Lee, Jimmy S.
    Nauseef, William M.
    Moeenrezakhanlou, Alireza
    Sly, Laura M.
    Noubir, Sanaa
    Leidal, Kevin G.
    Schlomann, Jamie M.
    Krystal, Gerald
    Reiner, Neil E.
    JOURNAL OF LEUKOCYTE BIOLOGY, 2007, 81 (06) : 1548 - 1561
  • [33] Idelalisib, an inhibitor of phosphatidylinositol 3-kinase p110δ, for relapsed/refractory chronic lymphocytic leukemia
    Brown, Jennifer R.
    Byrd, John C.
    Coutre, Steven E.
    Benson, Don M.
    Flinn, Ian W.
    Wagner-Johnston, Nina D.
    Spurgeon, Stephen E.
    Kahl, Brad S.
    Bello, Celeste
    Webb, Heather K.
    Johnson, Dave M.
    Peterman, Sissy
    Li, Daniel
    Jahn, Thomas M.
    Lannutti, Brian J.
    Ulrich, Roger G.
    Yu, Albert S.
    Miller, Langdon L.
    Furman, Richard R.
    BLOOD, 2014, 123 (22) : 3390 - 3397
  • [34] The catalytic phosphoinositol 3-kinase isoform p110δ is required for glioma cell migration and invasion
    Luk, Sze Ki
    Piekorz, Roland P.
    Nuernberg, Bernd
    To, Shing-Shun Tony
    EUROPEAN JOURNAL OF CANCER, 2012, 48 (01) : 149 - 157
  • [35] The p110δ isoform of phosphoinositide 3-kinase controls clonal expansion and differentiation of Th cells
    Okkenhaug, Klaus
    Patton, Daniel T.
    Bilancio, Antonio
    Garcon, Fabien
    Rowan, Wendy C.
    Vanhaesebroeck, Bart
    JOURNAL OF IMMUNOLOGY, 2006, 177 (08): : 5122 - 5128
  • [36] Targeting the phosphoinositide 3-kinase isoform p110δ impairs growth and survival in neuroblastoma cells
    Boller, Danielle
    Schramm, Alexander
    Doepfner, Kathrin T.
    Shalaby, Tarek
    von Bueren, Andre O.
    Eggert, Angelika
    Grotzer, Michael A.
    Arcaro, Alexandre
    CLINICAL CANCER RESEARCH, 2008, 14 (04) : 1172 - 1181
  • [37] Expression of the phosphoinositide 3-kinase p110δ isoform and its clinicopathological significance in gastric cancer
    Ji, Byounghoon
    Lee, Hyoun Wook
    Lee, Eun Hee
    Park, Moon-Il
    Kim, Mee-Seon
    Kim, Kyungeun
    Roh, Mee Sook
    Kim, Seok-Hyun
    Ji, Jun Ho
    Kim, Kwang Min
    Oh, Jieun
    Kim, Yong Seok
    Choi, Seong Hee
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (09): : 9415 - 9421
  • [38] Critical roles for the phosphatidylinositide 3-kinase isoforms p110β and p110γ in thrombopoietin-mediated priming of platelet function
    Samantha F. Moore
    Nina R. Smith
    Thomas A. Blair
    Tom N. Durrant
    Ingeborg Hers
    Scientific Reports, 9
  • [39] Critical roles for the phosphatidylinositide 3-kinase isoforms p110β and p110γ in thrombopoietin-mediated priming of platelet function
    Moore, Samantha F.
    Smith, Nina R.
    Blair, Thomas A.
    Durrant, Tom N.
    Hers, Ingeborg
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [40] Oncogenic transformation induced by the p110β, -γ, and -δ isoforms of class I phosphoinositide 3-kinase
    Kang, S
    Denley, A
    Vanhaesebroeck, B
    Vogt, PK
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (05) : 1289 - 1294